merged_adhd-life-expectancy.txt
<question_number>1</question_number>
<answer>JAMA meta‑analysis measured only unnatural‑cause deaths, while the British study measured all‑cause mortality/life expectancy.</answer>
<question_number>2</question_number>
<answer>No cause‑of‑death data means it’s unclear whether smoking or personality disorders actually drove the deaths, so prevention based only on those comorbidities may be misdirected.</answer>
<question_number>3</question_number>
<answer>N/A</answer>
<question_number>4</question_number>
<answer>Surging first‑time adult diagnoses—especially among women and people of color—despite stable childhood rates, showing many previously undiagnosed cases that could alter mortality estimates.</answer>
<question_number>5</question_number>
<answer>Adderall shortage began after the 2000‑2019 study period, so it could not confound those mortality calculations.</answer>
